Feng W - Search Results

1

Chronic intermittent hypoxia contributes to non-alcoholic steatohepatitis progression in patients with obesity.

Fu Y, Zhang N, Tang W, Bi Y, Zhu D, Chu X, Shan X, Shen Y, Sun X, Feng W. Fu Y, et al. Among authors: feng w. Hepatol Int. 2022 Aug;16(4):824-834. doi: 10.1007/s12072-022-10347-2. Epub 2022 Jun 6. Hepatol Int. 2022. PMID: 35668285

2

Decreased beta cell function and insulin sensitivity contributed to increasing fasting glucose in Chinese.

Bi Y, Zhu D, Jing Y, Hu Y, Feng W, Shen S, Tong G, Shen X, Yu T, Song D, Yang D. Bi Y, et al. Among authors: feng w. Acta Diabetol. 2012 Dec;49 Suppl 1:S51-8. doi: 10.1007/s00592-010-0194-4. Epub 2010 May 15. Acta Diabetol. 2012. PMID: 20473530

3

SGK1 is regulated by metabolic-related factors in 3T3-L1 adipocytes and overexpressed in the adipose tissue of subjects with obesity and diabetes.

Li P, Pan F, Hao Y, Feng W, Song H, Zhu D. Li P, et al. Among authors: feng w. Diabetes Res Clin Pract. 2013 Oct;102(1):35-42. doi: 10.1016/j.diabres.2013.08.009. Epub 2013 Aug 31. Diabetes Res Clin Pract. 2013. PMID: 24035040

4

Low serum sex hormone-binding globulin is associated with nonalcoholic fatty liver disease in type 2 diabetic patients.

Hua X, Sun Y, Zhong Y, Feng W, Huang H, Wang W, Zhang T, Hu Y. Hua X, et al. Among authors: feng w. Clin Endocrinol (Oxf). 2014 Jun;80(6):877-83. doi: 10.1111/cen.12360. Epub 2013 Dec 5. Clin Endocrinol (Oxf). 2014. PMID: 24303796

5

Correlations between A1c, fasting glucose, 2h postload glucose, and β-cell function in the Chinese population.

Li C, Yang H, Tong G, Shen S, Feng W, Bi Y, Zhu D. Li C, et al. Among authors: feng w. Acta Diabetol. 2014 Aug;51(4):601-8. doi: 10.1007/s00592-014-0563-5. Epub 2014 Mar 5. Acta Diabetol. 2014. PMID: 24595519

6

Effects of exenatide, insulin, and pioglitazone on liver fat content and body fat distributions in drug-naive subjects with type 2 diabetes.

Bi Y, Zhang B, Xu W, Yang H, Feng W, Li C, Tong G, Li M, Wang X, Shen S, Zhu B, Weng J, Zhu D. Bi Y, et al. Among authors: feng w. Acta Diabetol. 2014 Oct;51(5):865-73. doi: 10.1007/s00592-014-0638-3. Epub 2014 Aug 14. Acta Diabetol. 2014. PMID: 25118999 Clinical Trial.

7

Comparative efficacy of anti-diabetic agents on nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized and non-randomized studies.

Tang W, Xu Q, Hong T, Tong G, Feng W, Shen S, Bi Y, Zhu D. Tang W, et al. Among authors: feng w. Diabetes Metab Res Rev. 2016 Feb;32(2):200-16. doi: 10.1002/dmrr.2713. Epub 2015 Nov 1. Diabetes Metab Res Rev. 2016. PMID: 26381272 Review.

8

Effects of Exenatide on Metabolic Changes, Sexual Hormones, Inflammatory Cytokines, Adipokines, and Weight Change in a DHEA-Treated Rat Model.

Sun L, Ji C, Jin L, Bi Y, Feng W, Li P, Shen S, Zhu D. Sun L, et al. Among authors: feng w. Reprod Sci. 2016 Sep;23(9):1242-9. doi: 10.1177/1933719116635278. Epub 2016 Feb 25. Reprod Sci. 2016. PMID: 26917422

9

Randomized trial comparing the effects of gliclazide, liraglutide, and metformin on diabetes with non-alcoholic fatty liver disease.

Feng W, Gao C, Bi Y, Wu M, Li P, Shen S, Chen W, Yin T, Zhu D. Feng W, et al. J Diabetes. 2017 Aug;9(8):800-809. doi: 10.1111/1753-0407.12555. Epub 2017 May 29. J Diabetes. 2017. PMID: 28332301 Clinical Trial.

10

Modulation of gut microbiota contributes to curcumin-mediated attenuation of hepatic steatosis in rats.

Feng W, Wang H, Zhang P, Gao C, Tao J, Ge Z, Zhu D, Bi Y. Feng W, et al. Biochim Biophys Acta Gen Subj. 2017 Jul;1861(7):1801-1812. doi: 10.1016/j.bbagen.2017.03.017. Epub 2017 Mar 21. Biochim Biophys Acta Gen Subj. 2017. PMID: 28341485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,982 results

Search Page

Filters